9.03
price down icon2.27%   -0.21
after-market アフターアワーズ: 9.03
loading
前日終値:
$9.24
開ける:
$9.3
24時間の取引高:
509.79K
Relative Volume:
0.61
時価総額:
$642.67M
収益:
$133.62M
当期純損益:
$-177.37M
株価収益率:
-3.1246
EPS:
-2.89
ネットキャッシュフロー:
$23.50M
1週間 パフォーマンス:
-0.77%
1か月 パフォーマンス:
+10.93%
6か月 パフォーマンス:
-53.21%
1年 パフォーマンス:
-58.29%
1日の値動き範囲:
Value
$9.02
$9.445
1週間の範囲:
Value
$8.99
$9.69
52週間の値動き範囲:
Value
$7.16
$27.24

Xencor Inc Stock (XNCR) Company Profile

Name
名前
Xencor Inc
Name
セクター
Healthcare (1164)
Name
電話
626-305-5900
Name
住所
465 N. HALSTEAD ST., PASADENA, CA
Name
職員
250
Name
Twitter
Name
次回の収益日
2024-11-05
Name
最新のSEC提出書
Name
XNCR's Discussions on Twitter

XNCR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
XNCR
Xencor Inc
9.03 657.62M 133.62M -177.37M 23.50M -2.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.83 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.63 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.79 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
595.19 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.51 31.54B 3.81B -644.79M -669.77M -6.24

Xencor Inc Stock (XNCR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-21 開始されました William Blair Outperform
2024-12-12 開始されました Wells Fargo Overweight
2024-12-02 アップグレード Piper Sandler Neutral → Overweight
2024-04-16 繰り返されました BTIG Research Buy
2024-02-28 ダウングレード Piper Sandler Overweight → Neutral
2023-05-19 開始されました BofA Securities Buy
2022-12-06 開始されました Cowen Outperform
2022-10-13 アップグレード Raymond James Outperform → Strong Buy
2022-09-21 開始されました JP Morgan Overweight
2022-07-06 再開されました Canaccord Genuity Buy
2022-02-11 開始されました BMO Capital Markets Outperform
2022-01-21 開始されました SMBC Nikko Outperform
2021-12-15 開始されました H.C. Wainwright Buy
2021-10-15 再開されました BTIG Research Buy
2021-02-24 アップグレード Raymond James Mkt Perform → Outperform
2020-03-04 開始されました Barclays Underweight
2020-02-25 アップグレード Guggenheim Neutral → Buy
2020-01-30 開始されました RBC Capital Mkts Outperform
2019-11-20 再開されました Guggenheim Neutral
2019-08-07 ダウングレード Guggenheim Buy → Neutral
2019-08-07 ダウングレード Raymond James Outperform → Mkt Perform
2019-06-13 開始されました Mizuho Buy
2019-04-12 開始されました Guggenheim Buy
2019-03-27 開始されました Berenberg Buy
2019-03-15 開始されました Raymond James Outperform
2018-09-10 再開されました BTIG Research Buy
2018-03-28 再開されました Leerink Partners Outperform
2017-03-02 開始されました Instinet Neutral
2017-03-02 繰り返されました Wedbush Outperform
2016-10-04 開始されました Piper Jaffray Overweight
2015-12-22 開始されました Canaccord Genuity Buy
2015-08-05 繰り返されました MLV & Co Buy
2015-02-12 繰り返されました Oppenheimer Outperform
2015-01-28 繰り返されました MLV & Co Buy
2014-07-11 開始されました Oppenheimer Outperform
すべてを表示

Xencor Inc (XNCR) 最新ニュース

pulisher
Jul 28, 2025

What is the risk reward ratio of investing in Xencor Inc. stockPowerful profit generation - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Moving Average Trends for Xencor Inc. Stock: What They IndicateAnalyst Grade Signals - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Price action breakdown for Xencor Inc.Free Early Breakout Entry Point Notifications - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Signal strength of Xencor Inc. stock in tech scannersValue Investing Checklist with Entry Signals - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Xencor, Inc. (NASDAQ:XNCR) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Jul 28, 2025
pulisher
Jul 28, 2025

What is the dividend policy of Xencor Inc. stockBuild a diversified portfolio for risk management - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Should I hold or sell Xencor Inc. stock in 2025Discover high-impact investment opportunities - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are Xencor Inc. company’s key revenue driversTremendous growth opportunities - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Xencor Inc. Company’s Quarterly Earnings Growth: What the Numbers SayHigh Yield Opportunities - metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

When is Xencor Inc. stock expected to show significant growthOutstanding trading profits - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is it the right time to buy Xencor Inc. stockBuild a portfolio for long-term financial success - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What makes Xencor Inc. stock price move sharplyLow Risk ROI Maximization - metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

Does Xencor Inc. stock pay reliable dividendsHigh Potential Shares - Newser

Jul 27, 2025
pulisher
Jul 26, 2025

Why Xencor Inc. stock attracts strong analyst attentionSecure Growth Trading Plan - metal.it

Jul 26, 2025
pulisher
Jul 26, 2025

Insider Selling: Xencor, Inc. (NASDAQ:XNCR) VP Sells $21,244.68 in Stock - 富途牛牛

Jul 26, 2025
pulisher
Jul 26, 2025

Bank of New York Mellon Corp Reduces Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Jul 26, 2025
pulisher
Jul 25, 2025

Is Xencor Inc. a good long term investmentOver 200% growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Xencor Inc. Stock Analysis and ForecastRobust investment performance - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Xencor Inc. stock priceOutstanding investment returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

How Xencor Inc. stock performs during market volatilityDaily Top Gainers - Newser

Jul 25, 2025
pulisher
Jul 23, 2025

What analysts say about Xencor Inc. stockUnmatched profit growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Arizona State Retirement System - Defense World

Jul 23, 2025
pulisher
Jul 21, 2025

Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Teacher Retirement System of Texas - Defense World

Jul 21, 2025
pulisher
Jul 19, 2025

Where are the Opportunities in (XNCR) - news.stocktradersdaily.com

Jul 19, 2025
pulisher
Jul 19, 2025

What risks could impact Xencor Inc. stock performanceVerified Return Tips - Newser

Jul 19, 2025
pulisher
Jul 18, 2025

Xencor’s Phase 2 Study on Vudalimab in Prostate Cancer: Key Update and Market Impact - The Globe and Mail

Jul 18, 2025

Xencor Inc (XNCR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
大文字化:     |  ボリューム (24 時間):